• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA ETEST® METRONIDAZOLE MZH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA ETEST® METRONIDAZOLE MZH Back to Search Results
Catalog Number 530018
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Patient Involvement (2645)
Type of Reportable Event Malfunction
Event or Problem Description
A customer in (b)(6) notified biomerieux of discrepant results associated with etestetronidazole mzh 256 (reference 530018).The customer reported low minimum inhibitory concentration (mic) results involving a control strain escherichia coli atcc 25285.An investigation into the event will be initiated by biomerieux.
 
Additional Manufacturer Narrative
An internal biomérieux investigation was conducted due to low mic results with b.Fragilis atcc 25285 on etest® metronidazole mzh 256 ww f100 ref 530018.Lots tested: 1002689900, 1003007690, 1003409180, 1003827270.A reference lot was also used for testing.Due to the absence of customer return, testing was only done on retention lots.Customer results: agar : home-made (anaeroplates without antibiotics), oxoid or bd.Results below the range for the strain atcc 25285 e.Coli.Deviations: use of 0.85% nacl for the suspension instead of broth of brucella mh, incubation time of 18 hours.Unconfirmed at 48 hours.Use of mueller hinton.Investigation results: at 24 hours of incubation with lot 1003409180, results of atcc 29741 and atcc 25285 are orl in comparison to the ranges at 48 hours of incubation.Ranges for 24 hours incubation don't exist.Conclusion: following investigation several hypotheses were formulated that could explain the issue observed by the customer old investigation on etest® metronidazole showed results orl for b.Fragilis atcc 25285 after 24 hours incubation.For anaerobe strains: media: brucella agar- 5% blood-vitamin k (mcg/ml)- hemin (5mcg/ml) and not mueller hinton agar.Inoculum suspension should be prepared in brucella broth, mh broth or schaedler broth + vitamin k3.(0.85% nacl should not be used).Qc ranges are validated after 48 hours of incubation, not at 24 hours.In addition, other recommendations for anaerobes were included: for patient strains all "s" results must be confirmed at 48 hours of incubation.Do not vortex.Anaerobiosis must be achieve within 1-2 hours for metronidazole.In conclusion, the results of the microbiological quality control are in accordance with the expected specifications for all batches on e.Coli atcc 25922, b.Thetaiotaomicron atcc 29741 and b.Fragilis atcc 25285 after 48 hours of incubation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ETEST® METRONIDAZOLE MZH
Common Device Name
ETEST® METRONIDAZOLE MZH
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme les grottes isere, 38390
FR  38390
MDR Report Key5627668
Report Number3002769706-2016-00081
Device Sequence Number11844590
Product Code JWY
Combination Product (Y/N)N
PMA/510(K) Number
K913459
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional,u
Type of Report Initial,Followup
Report Date (Section B) 04/05/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/16/2018
Device Catalogue Number530018
Device Lot Number1002689900
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 04/05/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date05/03/2016
Supplement Report FDA Received Date07/08/2016
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-